Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis.
about
Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathwaysPPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1Genetically manipulated mouse models of lung disease: potential and pitfallsExtracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach.The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis.Fra-2 negatively regulates postnatal alveolar septation by modulating myofibroblast function.Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi.Aortic carboxypeptidase-like protein, a WNT ligand, exacerbates nonalcoholic steatohepatitis.Bi-allelic Alterations in AEBP1 Lead to Defective Collagen Assembly and Connective Tissue Structure Resulting in a Variant of Ehlers-Danlos Syndrome.Aortic carboxypeptidase-like protein enhances adipose tissue stromal progenitor differentiation into myofibroblasts and is upregulated in fibrotic white adipose tissue.Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes.
P2860
Q24611248-0D8F4E1E-A880-488D-B212-B1415BBFC476Q24633440-DD8A87DA-D3E2-48AC-8788-6253A7C082ACQ28388821-17B857C3-C78B-4191-AA41-45250A7A6A29Q35144146-B90B3884-FDDB-4A9B-A5E1-4410878B5E10Q41837635-B622797A-117F-4B68-9108-854400477D7CQ46539847-BF33C97E-EB7D-4172-8754-B1F387848F3BQ48134910-D4974666-C0D5-47F7-9565-9644E29FB59DQ52350739-771A4A36-87FF-452E-ADF8-211F3FA034B9Q52615325-235A8E4D-C2F6-48A0-9245-BCE5A6D46020Q54978248-365287CB-8BC3-4C14-9398-2C7E31B61943Q55442577-307953E9-257D-4C72-A92E-FBFE9CAE495C
P2860
Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aortic carboxypeptidase-like p ...... eomycin-induced lung fibrosis.
@en
Aortic carboxypeptidase-like p ...... eomycin-induced lung fibrosis.
@nl
type
label
Aortic carboxypeptidase-like p ...... eomycin-induced lung fibrosis.
@en
Aortic carboxypeptidase-like p ...... eomycin-induced lung fibrosis.
@nl
prefLabel
Aortic carboxypeptidase-like p ...... eomycin-induced lung fibrosis.
@en
Aortic carboxypeptidase-like p ...... eomycin-induced lung fibrosis.
@nl
P2093
P2860
P1476
Aortic carboxypeptidase-like p ...... leomycin-induced lung fibrosis
@en
P2093
Mark A Perrella
Robert W Shine
Sarah E Dunsmore
Scott L Schissel
Xiaoli Liu
P2860
P304
P356
10.2353/AJPATH.2009.080856
P407
P577
2009-01-29T00:00:00Z